David Pawlyk - Concepedia

Author

David Pawlyk

Center for Molecular Medicine and Immunology

Also Known As

D A Pawlyk, D Pawlyk, David A. Pawlyk, David Pawlyk

Publications

398

Citations

H-Index

Concepts

All Affiliations

Center for Molecular Medicine and Immunology Morristown Medical Center Temple University Hospital Memorial Sloan Kettering Cancer Center

About

David Pawlyk is an author at Center for Molecular Medicine and Immunology specializing in radiation oncology, radiation therapy, and nuclear medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	225
2	Pathology	3	3	225
3	Health Sciences	2	2	124
4	Immunology	2	2	164
5	Hepatology	1	1	61

David Pawlyk

Publications

398

Citations

H-Index

Page 1

	Year	Citations
Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts. R M Sharkey, Cecilia Motta‐Hennessy, David Pawlyk, PubMed ImmunologyPathologyTumor/nontumor RatiosTumor UptakeTumor Biology	1990	105
Sacral scintigraphy for bone marrow dosimetry in radioimmunotherapy Jeffry A. Siegel, Robert E. Lee, David Pawlyk, International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology Medical ImagingRadiation TherapyHematologyRadiopharmaceutical TherapySacral Scintigraphy	1989	63
Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibody. J A Siegel, David Pawlyk, Robert Lee, PubMed PathologyRed MarrowRed Marrow DoseHematological MalignancyOncology	1990	61
Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14 Robert M. Sharkey, David M. Goldenberg, Sumathi Murthy, Cancer	1993	59
Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans. R M Sharkey, D M Goldenberg, H Goldenberg, PubMed Immunocytochemical TechniqueImmunologyPathologyMab RatioImmunotherapy	1990	59
Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti‐idiotype antibody in tumor‐bearing nude mice Robert M. Sharkey, Otto C. Boerman, A. Natale, International Journal of Cancer	1992	30
Phase I clinical evaluation of a new murine monoclonal antibody (mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas Robert M. Sharkey, David M. Goldenberg, R. Vagg, Cancer	1994	21

Page 1